Opdyta Nivolumab 40mg Infusion

Description

Introduction Of Opdyta 40mg Injection:

Opdyta 40mg Injection contains Nivolumab, an immune checkpoint inhibitor used in the treatment of advanced melanoma, non-small cell lung cancer, renal cell carcinoma, Hodgkin lymphoma, head and neck cancer, and several other advanced cancers.

Opdyta 40mg Injection is administered only by a trained oncologist as a slow intravenous infusion, usually over 60 minutes, given once every 2 to 4 weeks depending on the treatment plan. Your doctor will decide the dose and whether it is used alone or combined with other cancer medicines such as ipilimumab or chemotherapy. It should never be self-administered.

Because this medicine works by activating the immune system, it can sometimes cause the immune system to attack healthy tissues as well. Fatigue, rash, itching, diarrhea, and joint or muscle pain are among the most common effects. Your doctor will monitor you closely for signs of inflammation in the lungs, intestines, liver, kidneys, skin, or hormone glands. Inform your doctor immediately if you notice persistent cough or shortness of breath, severe diarrhea or abdominal pain, yellowing of the skin or eyes, or unusual fatigue.

Uses Of Opdyta 40mg Injection:

• Advanced Melanoma
• Non-Small Cell Lung Cancer
• Renal Cell Carcinoma (Kidney Cancer)
• Hodgkin Lymphoma
• Head and Neck Cancer
• Advanced Gastric, Oesophageal, and Hepatocellular Cancer

Benefits Of Opdyta 40mg Injection:

1. Advanced Melanoma

Melanoma is a serious form of skin cancer that can spread to other organs. Opdyta 40mg Injection, alone or combined with ipilimumab, helps release a natural brake on the immune system, allowing T-cells to recognize and attack melanoma cells more effectively.

2. Non-Small Cell Lung Cancer and Other Cancers

In advanced lung, kidney, head and neck, and certain gastrointestinal cancers, Opdyta 40mg Injection blocks a protein that cancer cells use to switch off the immune system, helping restore the body’s ability to fight the cancer and slow disease progression.

Side effects of Opdyta 40mg Injection:

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.

Common side effects of Nivolumab:

• Fatigue
• Rash
• Itching
• Diarrhea
• Nausea
• Musculoskeletal pain
• Cough
• Shortness of breath
• Decreased appetite
• Joint pain
• Fever

Machanism Of Action Of Opdyta 40mg Injection:

Opdyta Injection contains Nivolumab, a monoclonal antibody that blocks a receptor on T-cells called PD-1. Normally, cancer cells use proteins such as PD-L1 to bind to PD-1 and switch off T-cell activity, helping the tumor evade the immune system. By blocking PD-1, Nivolumab prevents this shutdown, allowing T-cells to remain active and attack the cancer cells.

Contact Us